Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Ranisen | HCID 5039 | — |
| Solvent | Water | HCID 962 | — |
| Product | Zantac | HCID 47909 | — |
Reaction Steps
The seeding material of pure Form 1 ranitidine hydrochloride may be prepared by dissolving ranitidine in a solvent, preferably methylene chloride, at room temperature (20° to 25° C.), wherein the ratio of ranitidine to methylene chloride is from about 1:1 to 1:5, preferably 1:4, and treating the solution thus obtained with aqueous concentrated hydrochloric acid (e. g., 35 to 38% w/w). The hydrochloric acid and ranitidine may be mixed without cooling to form a reaction mixture. Preferably, however, the hydrochloric acid and ranitidine are mixed with cooling at -5° C. to 10° C. The reaction mixture is then heated under reflux and during heating, water is stripped off under azeotropic conditions. Preferably, the reaction mixture is heated under reflux for at least 4 hours, more preferably for approximately 6.5 hours. Alternatively, the reaction may be carried out under mild reaction conditions, such as, for example from 0° to 10° C. up to 20° to 25° C. for approximately 6.5 hours. The Form 1 ranitidine hydrochloride crystals that are formed are then filtered off from the crystallization medium, washed with ethanol and dried.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05663381 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-3a22675c34ce4c00856cd4ca45cdc04c |
|---|
| Source note | uspto-grants-1997_09 |
|---|